24 May 2013
Keywords: alimta, gemzar, herald, new, era, patient-centered, cancer
Article | 11 July 2005
US drug major Eli Lilly presented new data on its approved anticancer drugs Alimta (pemextred) and Gemzar (gemcitabine) demonstrating
Enjoying this article? To continue reading you need to login or subscribe.
Subscriptions are £60 per month, pay as you go.
Find out more details.
11 July 2005
18 July 2005
© 2013 thepharmaletter.com